Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.
An efficient procedure for the generation of sequence-specific alterations of the vaccinia virus genome was demonstrated. Homologous DNA recombination within cells infected with vaccinia virus was used for the deletion or replacement of promoter sequences of the viral growth factor gene by a procedure comparable to transplacement in Saccharomyces cerevisiae. This DNA replacement procedure can potentially be used to generate any sequence alteration within the vaccinia virus genome. Deletion of growth factor promoter sequences resulted in a dramatic reduction in growth factor gene transcription and protein synthesis. Replacement of growth factor promoter sequences with promoter sequences of the strong constitutive 40-kDa gene resulted in an increase in gene transcription and protein synthesis and an altered temporal pattern of expression. Virus containing mutations in the growth factor gene demonstrated different plaque morphologies on cell culture monolayers.
Spyropoulos
D D
DD
Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts 02115.
Stallard
V
V
Roberts
B E
BE
Cohen
L K
LK
D001483:Base Sequence; D015152:Blotting, Northern; D004252:DNA Mutational Analysis; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral; D006133:Growth Substances / Q000235:genetics*; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D014176:Protein Biosynthesis; D012333:RNA, Messenger; D011995:Recombination, Genetic; D014158:Transcription, Genetic; D014616:Vaccinia virus / Q000235:genetics* / Q000254:growth & development; D010948:Viral Plaque Assay; D015678:Viral Structural Proteins / Q000235:genetics
D006133:Growth Substances; D012333:RNA, Messenger; D015678:Viral Structural Proteins